| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 96,170 | 92,385 | 93,496 | 116,166 | | Cost of Revenue | 79,840 | 76,294 | 77,917 | 94,113 | | | Gross Profit | 16,330 | 16,091 | 15,579 | 22,053 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,832 | 4,514 | 4,646 | 6,032 | | Non Recurring | 2 | (20) | 19 | 34 | | Others | 12,997 | 12,192 | 12,548 | 13,392 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,501) | (595) | (1,634) | 2,595 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 39 | 16 | 19 | 38 | | Earnings Before Interest And Taxes | (1,462) | (579) | (1,615) | 2,633 | | Interest Expense | 655 | 725 | 881 | 1,136 | | Income Before Tax | (2,117) | (1,304) | (2,496) | 1,497 | | Income Tax Expense | (480) | (156) | (616) | 898 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,637) | (1,148) | (1,880) | 599 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,637) | (1,148) | (1,880) | 599 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,637) | ($1,148) | ($1,880) | $599 |
|
0.51% Nasdaq 
Income Statement
